IP Library Granted Patent US 7,890,173
Granted Patent B2
US 7,890,173 · App. 12/554,181 · Granted Feb 15, 2011

Implantable transducer devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,890,173
App. No.
12/554,181
Granted
Feb 15, 2011
Kind
B2
Abstract

Receiver-stimulators comprise a nearly isotropic transducer assembly, demodulator circuitry, and at least two tissue contacting electrodes. Use of near isotropic transducers allows the devices to be implanted with less concern regarding the orientation relative to an acoustic energy source. Transducers or transducer elements having relatively small sizes, typically less than ½ the wavelength of the acoustic source, enhance isotropy. The use of single crystal piezoelectric materials enhance sensitivity.

Claims (25)

1. A method for delivering a biologically stimulating electrical output, said method comprising:

implanting in tissue an isotropic receiver-stimulator having an acoustic transducer assembly;

coupling an acoustic energy source to the patient;

directing acoustic energy from the acoustic energy source to the isotropic receiver-stimulator,

wherein the acoustic energy that intersects the isotropic receiver-stimulator is transferred into the transducer assembly in a manner that is substantially insensitive to the relative orientation of the receiver-stimulator to the acoustic energy source, wherein the acoustic energy is converted by the transducer assembly into electrical signals;

wherein the electrical signals are demodulated by the receiver-stimulator to produce a biologically stimulating electrical output; and

wherein the biologically stimulating electrical output is delivered to the tissue by the receiver-stimulator.

2. A method as in claim 1 , wherein the transducer assembly produces electrical signals that vary by no more than ±6 dB as the orientation of the receiver-stimulator relative to the acoustic source varies.

3. A method as in claim 1 , wherein the acoustic energy is directed to the isotropic receiver-stimulator from an external acoustic source.

4. A method as in claim 1 , wherein the acoustic energy is directed to the isotropic receiver-stimulator from an implanted acoustic source.

5. A method as in claim 1 , wherein the biologically stimulating electrical output comprises a cardiac pacing waveform.

6. A method as in claim 1 , wherein the transducer assembly comprises a plurality of individual transducer elements, and wherein the demodulation is done using demodulator circuitry comprising a plurality of individual demodulator circuits, with the electrical signal from each transducer element going to a demodulator circuit which produces an output, and wherein the demodulator circuitry further comprises summing circuitry which sum all of the converted electrical signals from all of the demodulator circuits to produce the biologically stimulating electrical output.

7. A method for optimizing delivery of a biologically stimulating electrical output, said method comprising:

implanting a receiver-stimulator having an acoustic transducer assembly in tissue;

coupling an acoustic energy source to the patient;

directing acoustic energy from the acoustic energy source to the implanted receiver-stimulator, wherein the transducer assembly converts the acoustic energy into electrical signals that are characterized by a source impedance;

wherein the electrical signals are demodulated by the receiver-stimulator to produce a biologically stimulating electrical output;

wherein the biologically stimulating electrical output is delivered to the tissue by the receiver-stimulator, and wherein the tissue is characterized by a load impedance; and

wherein the source impedance is matched to the load impedance.

8. The method of claim 7 , wherein the transducer assembly comprises a plurality of individual transducer elements, and wherein the demodulation is done using demodulator circuitry comprising a plurality of individual demodulator circuits, with the electrical signal from each transducer element going to a demodulator circuit which produces an output, and wherein the demodulator circuitry further comprises summing circuitry which sum all of the converted electrical signals from all of the demodulator circuits to produce the biologically stimulating electrical output.

9. The method of claim 7 , wherein the receiver-stimulator is adapted to receive acoustic energy in a substantially isotropic manner.

10. The method of claim 7 , wherein the acoustic energy is directed to the receiver-stimulator from an external acoustic source.

11. The method of claim 7 , wherein the acoustic energy is directed to the receiver-stimulator from an implanted acoustic source.

12. The method of claim 7 , wherein the electrical output comprises a cardiac pacing waveform.

13. The method of claim 7 , wherein the impedance matching comprises selecting a configuration for multiple transducers and the demodulated electrical energy is summed in a series-parallel combination.

Assignments (2)
SECURITY INTEREST Recorded Jul 1, 2022
From: EBR SYSTEMS, INC.
To: RUNWAY GROWTH FINANCE CORP.
Reel/Frame 060560/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: BRISKEN, AXEL F.; COWAN, MARK W.; ECHT, DEBRA S.; RILEY, RICHARD E.
To: EBR SYSTEMS, INC.
Reel/Frame 042706/0393 →